Merck Total Long Term Liabilities 2010-2024 | MRK

Merck total long term liabilities for the quarter ending December 31, 2024 were $42.314B, a 2.38% decline year-over-year.

  • Merck total long term liabilities for 2024 were $42.314B, a 2.38% decline from 2023.
  • Merck total long term liabilities for 2023 were $43.346B, a 11.54% increase from 2022.
  • Merck total long term liabilities for 2022 were $38.863B, a 10.79% decline from 2021.

Merck Total Long Term Liabilities 2010-2024 | MRK

  • Merck total long term liabilities for 2024 were $42.314B, a 2.38% decline from 2023.
  • Merck total long term liabilities for 2023 were $43.346B, a 11.54% increase from 2022.
  • Merck total long term liabilities for 2022 were $38.863B, a 10.79% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B